Cargando…

Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial

Purpose: To evaluate the effect of Probiotic Streptococcus Salivarius K12 and M18 Lozenges on the Cariogram (Cariogram Mobile application Version 1.3 developed by Wong Jung Ming, Faculty of Dentistry, National University of Singapore) parameters of patients with high caries risk. Materials and Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Poorni, Saravanan, Nivedhitha, MS, Srinivasan, Manali, Balasubramaniam, Arthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012604/
https://www.ncbi.nlm.nih.gov/pubmed/35449617
http://dx.doi.org/10.7759/cureus.23282
_version_ 1784687831584604160
author Poorni, Saravanan
Nivedhitha, MS
Srinivasan, Manali
Balasubramaniam, Arthi
author_facet Poorni, Saravanan
Nivedhitha, MS
Srinivasan, Manali
Balasubramaniam, Arthi
author_sort Poorni, Saravanan
collection PubMed
description Purpose: To evaluate the effect of Probiotic Streptococcus Salivarius K12 and M18 Lozenges on the Cariogram (Cariogram Mobile application Version 1.3 developed by Wong Jung Ming, Faculty of Dentistry, National University of Singapore) parameters of patients with high caries risk. Materials and Methods: Fourty-two subjects were randomly allocated to Group 1 and 2 who received BLIS K12(TM )and BLIS M18(TM )probiotics (Blis Probiotics, Dunedin, New Zealand) respectively along with oral hygiene instructions and Group 3 (control) received only oral hygiene instructions with 1:1:1 allocation ratio. Subjects were instructed to follow the instructions and use the probiotics for a period of three months. Their caries risk was assessed using Cariogram software at baseline and 30 days after the use of probiotics. Change in the chance to avoid new cavities was recorded and statistically analysed using appropriate statistical tests. Results: About 38 subjects completed the trial with a drop-out count of eight. Multiple imputations were carried out for the missing data using an expectation-maximization algorithm. The mean percentage of actual chance to avoid new cavities was found to be 47.14 ± 6.837; 41.36 ± 16.04 and 32.50 ± 14.54 among the subjects in Group 1, Group 2, and Group 3 respectively. The mean percentage difference between the three groups was found to be statistically significant (p-value = 0.047). Dunn’s pair-wise comparison showed a significant mean percentage difference between Group 1 (BLIS K12) and Group 3 (control) (p=0.020). Conclusion: It can be concluded that the use of BLIS K12(TM )and BLIS M18(TM )probiotics for three months resulted in a considerable decrease in the caries risk. Further long-term clinical trials are needed to evaluate the difference in caries risk following the use of BLIS K12(TM)and BLIS M18(TM) among different age and risk groups.
format Online
Article
Text
id pubmed-9012604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90126042022-04-20 Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial Poorni, Saravanan Nivedhitha, MS Srinivasan, Manali Balasubramaniam, Arthi Cureus Preventive Medicine Purpose: To evaluate the effect of Probiotic Streptococcus Salivarius K12 and M18 Lozenges on the Cariogram (Cariogram Mobile application Version 1.3 developed by Wong Jung Ming, Faculty of Dentistry, National University of Singapore) parameters of patients with high caries risk. Materials and Methods: Fourty-two subjects were randomly allocated to Group 1 and 2 who received BLIS K12(TM )and BLIS M18(TM )probiotics (Blis Probiotics, Dunedin, New Zealand) respectively along with oral hygiene instructions and Group 3 (control) received only oral hygiene instructions with 1:1:1 allocation ratio. Subjects were instructed to follow the instructions and use the probiotics for a period of three months. Their caries risk was assessed using Cariogram software at baseline and 30 days after the use of probiotics. Change in the chance to avoid new cavities was recorded and statistically analysed using appropriate statistical tests. Results: About 38 subjects completed the trial with a drop-out count of eight. Multiple imputations were carried out for the missing data using an expectation-maximization algorithm. The mean percentage of actual chance to avoid new cavities was found to be 47.14 ± 6.837; 41.36 ± 16.04 and 32.50 ± 14.54 among the subjects in Group 1, Group 2, and Group 3 respectively. The mean percentage difference between the three groups was found to be statistically significant (p-value = 0.047). Dunn’s pair-wise comparison showed a significant mean percentage difference between Group 1 (BLIS K12) and Group 3 (control) (p=0.020). Conclusion: It can be concluded that the use of BLIS K12(TM )and BLIS M18(TM )probiotics for three months resulted in a considerable decrease in the caries risk. Further long-term clinical trials are needed to evaluate the difference in caries risk following the use of BLIS K12(TM)and BLIS M18(TM) among different age and risk groups. Cureus 2022-03-18 /pmc/articles/PMC9012604/ /pubmed/35449617 http://dx.doi.org/10.7759/cureus.23282 Text en Copyright © 2022, Poorni et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Preventive Medicine
Poorni, Saravanan
Nivedhitha, MS
Srinivasan, Manali
Balasubramaniam, Arthi
Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title_full Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title_fullStr Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title_full_unstemmed Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title_short Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
title_sort effect of probiotic streptococcus salivarius k12 and m18 lozenges on the cariogram parameters of patients with high caries risk: a randomised control trial
topic Preventive Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012604/
https://www.ncbi.nlm.nih.gov/pubmed/35449617
http://dx.doi.org/10.7759/cureus.23282
work_keys_str_mv AT poornisaravanan effectofprobioticstreptococcussalivariusk12andm18lozengesonthecariogramparametersofpatientswithhighcariesriskarandomisedcontroltrial
AT nivedhithams effectofprobioticstreptococcussalivariusk12andm18lozengesonthecariogramparametersofpatientswithhighcariesriskarandomisedcontroltrial
AT srinivasanmanali effectofprobioticstreptococcussalivariusk12andm18lozengesonthecariogramparametersofpatientswithhighcariesriskarandomisedcontroltrial
AT balasubramaniamarthi effectofprobioticstreptococcussalivariusk12andm18lozengesonthecariogramparametersofpatientswithhighcariesriskarandomisedcontroltrial